Combination chemotherapy (CMFVP) versus
β
Harold Glucksberg; Saul E. Rivkin; Shelley Rasmussen; Bill Tranum; Nazli Gad-el-
π
Article
π
1982
π
John Wiley and Sons
π
English
β 970 KB
The Southwest Oncology Group in a prospective randomized study compared one year of adjuvant combination chemotherapy with continuous CMFVP to two years of intermittent L-PAM in women with operable breast cancer with histologically positive axillary lymph nodes. In fully evaluable patients with a 42